Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

CES-EES Clinical Score and a Wearable Ring Sensor for Obstructive Sleep Apnea: Individual and Combined Validation Against In-Laboratory Polysomnography

21. august 2026 opdateret af: Goh Liang Chye, University of Malaya

Validation of Clinical Upper Airway Assessment Tool With Artificial Intelligence Wearable Technology Against In-Lab Polysomnography

This study evaluates whether a clinical upper airway assessment tool (the Clinical Examination Score plus ENT Examination Score, CES-EES) and an artificial-intelligence wearable ring (Belun Ring, Belun Sleep System BLS-100) can serve as accurate, less resource-intensive alternatives to in-lab polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA). Adults referred to the Otorhinolaryngology sleep clinic at Universiti Malaya Medical Centre (UMMC) for suspected OSA, who score 4 or more on the combined CES-EES scale, undergo a single overnight Level 1 in-lab PSG. The Belun Ring is worn concurrently with standard PSG electrodes during this same overnight study. The apnea-hypopnea index (AHI) from the Belun Ring and the CES-EES score, individually and in combination, are compared against the AHI from in-lab PSG -- the diagnostic reference standard -- to assess their agreement, correlation, and diagnostic accuracy for OSA.

Studieoversigt

Detaljeret beskrivelse

Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder associated with cardiovascular, cerebrovascular, and other long-term health consequences if untreated. In-lab polysomnography (PSG) is the diagnostic reference standard but is resource-intensive, costly, and associated with long waiting times. Existing screening tools such as the STOP-BANG questionnaire and the Epworth Sleepiness Scale (ESS) have recognized sensitivity/specificity trade-offs. The Clinical Examination Score (CES) combined with the ENT Examination Score (EES) is a previously described clinical scoring tool for OSA screening. The Belun Ring (Belun Sleep System BLS-100) is an FDA 510(k)-cleared (Class II), Malaysia Medical Device Authority-registered, AI/deep-learning-facilitated wearable capable of estimating AHI, sleep staging, and OSA severity.

This is a prospective, comparative, single-centre study conducted at Universiti Malaya Medical Centre (UMMC). Adults referred to the Otorhinolaryngology sleep clinic for suspected OSA, with high ESS and/or STOP-BANG scores, are screened with the CES-EES; those scoring 4 or more and otherwise meeting eligibility criteria are enrolled. After informed consent, participants undergo a standardised history, demographic data collection, and physical examination (oral cavity examination, flexible nasopharyngeal endoscopy, dental assessment), followed by a single overnight Level 1 in-lab PSG (Compumedics, 7-channel) at the UMMC Neurology Sleep Lab. The Belun Ring is fitted to the participant's index finger concurrently with standard PSG electrodes, so both devices record simultaneously during the same overnight study. A minimum of 4 hours total sleep time (TST) is required; participants with less than 4 hours TST are excluded from analysis. Both PSG and Belun Ring AHI are scored using AASM 1A criteria (hypopnea defined by desaturation of 3% or more). PSG is manually scored by a sleep technician; Belun Ring output is processed by the device's AI algorithm and independently cross-checked by two investigators.

The primary comparisons are: (1) CES-EES score against PSG AHI; (2) Belun Ring AHI against PSG AHI; and (3) CES-EES combined with Belun Ring AHI against PSG AHI. Planned statistical analyses include the paired t-test or Wilcoxon signed-rank test for comparative analysis, Bland-Altman plots for agreement/bias analysis, the intraclass correlation coefficient (ICC) for inter-scorer reliability, and descriptive statistics (mean, median, SD, range).

Undersøgelsestype

Observationel

Tilmelding (Anslået)

58

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Kuala Lumpur
      • Pantai Valley, Kuala Lumpur, Malaysia, 59100
        • Rekruttering
        • Universiti Malaya Medical Centre (UMMC)
        • Ledende efterforsker:
          • Varatha Raju Kugan, MD
        • Underforsker:
          • Liang Chye Goh, MBBS
        • Underforsker:
          • Kheng Seng Lim, MBBS

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Adults referred to the UMMC Otorhinolaryngology sleep clinic for sleep-related breathing disorders and scheduled for in-lab PSG

Beskrivelse

Inclusion Criteria:

  • ≥18 years old
  • Patients with suspected OSA (high ESS and/or STOP-BANG score)
  • CES-EES score 4 or more
  • Newly diagnosed cases
  • Minimum 4 hours of Total Sleep Time (TST)

Exclusion Criteria:

  • Active URTI (upper respiratory tract infection) in the past 1 month
  • Current smoker
  • Alcohol consumption within 8 hours prior to testing
  • History of head and neck carcinoma
  • Active respiratory or neurological disorders
  • Active psychiatric disorders and currently on psychiatric medication

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Adults with suspected OSA undergoing concurrent CES-EES scoring, Belun Ring monitoring, and in-lab P
Adults with suspected OSA undergoing concurrent CES-EES scoring, Belun Ring monitoring, and in-lab PSG
AI/deep-learning-facilitated wearable ring worn on the index finger concurrently with standard PSG electrodes during the overnight PSG study; estimates AHI, sleep stages, and OSA severity using AASM 1A scoring criteria (desaturation of 3% or more defines hypopnea).
Combined Clinical Examination Score (CES) and ENT Examination Score (EES), administered via history, oral cavity examination, flexible nasopharyngeal endoscopy, and dental assessment prior to PSG.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Apnea-Hypopnea Index (AHI)
Tidsramme: Baseline
AHI (events/hour) derived from polysomnogram or wearable sleep study, scored using AASM 1A criteria (desaturation of 3% or more defines hypopnea); output cross-checked by two independent investigators.
Baseline

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Sleep quality parameters
Tidsramme: Baseline
Total sleep time (TST), sleep latency, wake after sleep onset (WASO), sleep efficiency, and lowest oxygen saturation (LSAT)
Baseline
Epworth Sleepiness Scale (ESS) score
Tidsramme: Baseline
Self-reported daytime sleepiness questionnaire
Baseline

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Varatha Raju Kugan, MD, Department of Otorhinolaryngology, Head & Neck Surgery, Universiti Malaya Medical Centre

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. marts 2026

Primær færdiggørelse (Anslået)

1. marts 2027

Studieafslutning (Anslået)

1. marts 2027

Datoer for studieregistrering

Først indsendt

16. august 2026

Først indsendt, der opfyldte QC-kriterier

21. august 2026

Først opslået (Faktiske)

25. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

21. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner